A recent report has raised alarms about the risk of premature organ transplants for donors, prompting HHS Secretary Robert F. Kennedy Jr. to unveil a new initiative aimed at reforming the organ transplant system.
The New York Times’ report from July 20 highlighted troubling accounts from several families, who alleged that surgeons attempted to start organ recovery while patients were still alive or showing signs of improvement.
With the rising demand for transplants, the report suggests a rush in the organ retrieval process that may compromise patient safety.
A study from the Health Resources and Services Administration (HRSA) revealed that over 70 organ removals in Kentucky should have been called off earlier since patients exhibited signs of revival.
This issue seems connected to an increase in what are termed “postcirculatory donations,” where patients are not declared “brain dead” but are critically ill or injured. In these cases, life support is withdrawn, and organs may be taken shortly after the heart stops naturally.
The Times also indicated that 55 healthcare workers across 19 states have reported witnessing at least one alarming case of this type of donation.
Please seek reform
The U.S. Department of Health and Human Services (HHS) announced its initiative to rethink the organ transplant system in a recent statement.
This push followed findings that major organ procurement organizations were employing troubling practices, as unveiled by the HRSA investigation.
Kennedy mentioned that the inquiry showed hospitals allowed the organ procurement process to initiate even when there were signs of life in the patients.
“This is horrifying,” he remarked. “The institutions that oversee organ access must be held accountable. The whole system needs to be reevaluated to ensure the sanctity of life for all potential donors.”
The HRSA’s investigation was centered on how vulnerable patients are treated during organ procurement.
According to HHS, the HRSA has looked into 351 cases where organ donations were approved but not carried through, with 103 of these cases—or over 29%—indicating characteristics incompatible with organ donation. Notably, 73 patients showed neurological signs that contradicted their eligibility for donation.
The report raised ethical and legal concerns, particularly indicating that at least 28 patients may not have actually died when their organs were supposed to be procured.
The assessment pointed to shortcomings in the neurological evaluations, a lack of collaboration with healthcare teams, and misclassifications of death causes, especially in overdose situations.
To address these issues, organ procurement organizations must undergo strict corrective actions and implement system-level changes aimed at safeguarding potential donors.
CEO cites “fragmented surveillance”
Dr. Maureen McBride, CEO of the United Network for Organ Sharing (UNOS), responded to the New York Times report, describing the situation as “terrifying.”
She stated that the current operations fall drastically below what the American organ donation and transplantation system should maintain and must not be tolerated.
McBride emphasized the need for a more cohesive and accountable structure overseeing the organ donation and transplant system, noting the present “fragmented surveillance” shared by HRSA and the Centers for Medicare and Medicaid Services (CMS).
She advocated for enhanced integrated surveillance and patient safety reporting systems to ensure a “safe, effective and reliable” system while pointing out that the federal government is ultimately responsible for monitoring the system.
“UNOS continues to advocate for reforms to enhance the system. We look forward to discussing proposed changes with Congress soon to make substantial progress in partnership with the federal government,” she added.
Robert Montgomery, director of the NYU Langone Transplant Institute, highlighted that his facility adheres to strict protocols that prevent organ harvesting until five minutes have passed following circulatory death.
“This matter is taken very seriously,” he stated. “We maintain the highest ethical standards.”
He acknowledged the ongoing struggle with organ shortages that impact numerous lives.
Currently, HRSA reports that over 103,000 individuals are on the national transplant waiting list, with 13 people dying each day while awaiting transplants.
